This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Macular Pigment Optical Density in Healthy Subjects

This study has been terminated.
Information provided by (Responsible Party):
Gerhard Garhofer, Medical University of Vienna Identifier:
First received: October 9, 2009
Last updated: November 13, 2014
Last verified: November 2014

The macular pigment (MP) in humans consists of the yellow, blue-absorbing carotenoids lutein and zeaxanthin, which are contained in vegetables and fruits. The highest concentrations of lutein and zeaxanthin are found in the fovea. Since light entering the eye passes through the MP before reaching the photo receptors it absorbs a significant portion of short-wavelength light. There is evidence that these absorbing properties of the MP as well as the ability of inactivating highly reactive oxygen species are protective for the retina.

Measurement of macular pigment is difficult and the investigators have recently proposed a way of measuring macular pigment optical density (MPOD) based on optical reflectometry. There is increased interest in these measurements in the recent years, because a number of studies has provided evidence that low fruit and vegetable consumption increases the risk of age related macular degeneration (AMD). The present study investigates MP optical density (OD) in healthy volunteers and is used to form a database.

Furthermore the nutritional habits and the influence on MP density will be evaluated.

Age Related Macular Degeneration

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Macular Pigment Optical Density in Healthy Subjects

Resource links provided by NLM:

Further study details as provided by Gerhard Garhofer, Medical University of Vienna:

Primary Outcome Measures:
  • MPOD as measured with optical reflectometry [ Time Frame: 1 year ]

Enrollment: 96
Study Start Date: May 2009
Study Completion Date: December 2010
Primary Completion Date: September 2010 (Final data collection date for primary outcome measure)
20 healthy subjects between 18 and 40 years
20 healthy subjects between 41 and 50 years
20 healthy subjects between 51 and 60 years
20 healthy subjects between 61 and 70 years
20 healthy subjects between 71 and 80 years
20 healthy subjects between 81 and 90 years


Ages Eligible for Study:   18 Years to 90 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Healthy subjects

Inclusion Criteria:

  • Healthy subjects without any signs of AMD
  • Age between 18 and 90 years, (20 subjects aged between 18 and 40, 20 subjects aged between 41 and 50, 20 subjects aged between 51 and 60, 20 subjects aged between 61 and 70, 20 subjects aged between 71 and 80, 20 subjects aged between 81 and 90)
  • Clear non-lenticular ocular media
  • Visual acuity > 0.6

Exclusion Criteria:

  • Any sign of AMD, or another retinal or optic nerve head disease
  • Ocular surgery within the last 6 months
  • Treatment with photosensitizing drugs
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00993330

Department of Clinical Pharmacology, Medical University of Vienna
Vienna, Austria, 1090
Sponsors and Collaborators
Medical University of Vienna
Principal Investigator: Gerhard Garhofer, MD Medical University of Vienna
  More Information

Responsible Party: Gerhard Garhofer, Assoc. Prof. Priv. - Doz. Dr, Medical University of Vienna Identifier: NCT00993330     History of Changes
Other Study ID Numbers: OPHT-310109
Study First Received: October 9, 2009
Last Updated: November 13, 2014

Keywords provided by Gerhard Garhofer, Medical University of Vienna:
macular pigment
to measure macular pigment in the retina

Additional relevant MeSH terms:
Macular Degeneration
Retinal Degeneration
Retinal Diseases
Eye Diseases processed this record on September 21, 2017